Hospitals Ask U.S. Supreme Court to End “Crushing” Medicare Payments Cuts for 340B Drugs

Hospital groups expressed disappointment with a federal district judge's dismissal of their lawsuit seeking to prod HHS into action against drug companies denying 340B pricing on contract pharmacy drugs. | Shutterstock
Three national hospital groups and three hospitals yesterday asked the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient
Read More »

AHA Asks CMS to Rein In UHC’s Specialty Pharmacy Policies

The American Hospital Association says UnitedHealthcare's Specialty pharmacy coverage policies undermine the 340B program's intent. | Shutterstock
The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.
Read More »

Biden Administration Position in Supreme Court ACA Case Has 340B Implications

340B hospitals’ Medicare Part B payment challenge is not the only Supreme Court case next term that will impact the 340B program.
The Biden administration late yesterday told the U.S. Supreme Court that, due to the change in the presidency, the federal government has changed its main position in the lawsuit over the Affordable Care Act’s (ACA) constitutionality. The government now says
Read More »

Court Hearing Today on Hospitals’ 340B Contract Pharmacy Suit Against HHS

Under normal circumstances, today's hearing would be in this federal district courtroom in Oakland, Calif. It will be held virtually instead due to the COVID-19 pandemic.
A federal district judge in Oakland, Calif., is scheduled to hold a hearing this afternoon on the U.S. Health and Human Services (HHS) Department’s motion to dismiss a lawsuit against it by 340B hospitals over HHS’s enforcement of its 340B
Read More »

340B Report Publisher/CEO: It Will Take Time for Contract Pharmacy Battle to Play Out

Recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky’s take in his latest column for the Omnicell blog

The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report

Read More »

HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit

The lawsuit against HHS by 340B hospitals is just one of several underway over drug manufacturers’ denials of 340B pricing on drugs dispensed by contract pharmacies. | Source: Shutterstock
Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar last week asked a federal district judge to dismiss a lawsuit against him and his department by 340B hospitals over HHS’s enforcement of its 340B contract pharmacy requirements for drug
Read More »

Lilly Asks Court to Shield it From “Crippling” 340B Sanctions

Drug manufacturer Eli Lilly and Co. told a court this week that HHS has placed it in the "untenable position of offering 340B discounts that are not required by the statute or else facing crippling financial sanctions." | Source: Shutterstock
340B program stakeholders are still digesting drug manufacturers AstraZeneca, Eli Lilly and Co., and Sanofi’s Jan. 12 lawsuits to block federal sanctions over their decisions to stop or impose conditions on 340B discounts on drugs dispensed by contract pharmacies.
Read More »

AstraZeneca, Lilly, and Sanofi Sue HHS to Block Requirement To Give 340B Discounts To Contract Pharmacies

AstraZeneca, Eli Lilly and Co., and Sanofi sued HHS in defense of their 340B contract actions just hours before covered entities could begin challenging those actions in a new 340B administrative dispute resolution process. | Source: Shutterstock
In a major escalation of the fight over 340B contract pharmacy, drug manufacturer AstraZeneca late yesterday asked a federal court to declare that it “is not required to offer 340B discounts to contract pharmacies.”

Please Login

Read More »
Generic selectors
Exact matches only
Search in title
Search in content

Sign up for news summaries and alerts from 340B Report